Telesis Bio Inc. (TBIO)
0.29
0.00 (0.00%)
At close: Mar 31, 2025, 11:32 AM
Telesis Bio Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Revenue | 27.51M | 27.43M | 11.04M | 6.58M | 4.8M | 1.42M | n/a | n/a |
| Cost of Revenue | 10.56M | 11.84M | 6.74M | 2.95M | 8.89M | n/a | n/a | n/a |
| Gross Profit | 16.95M | 15.6M | 4.3M | 3.63M | -4.08M | 1.42M | n/a | n/a |
| Operating Income | -46.54M | -46.48M | -35.37M | -16.36M | -6.98M | -102.96M | -78.92M | -26.7M |
| Interest Income | 1.74M | 1.22M | 1.37M | 690K | 1.79M | 1.32M | 281K | 114K |
| Pretax Income | -47.7M | -48.45M | -38.94M | -18M | -8.3M | -102.96M | -78.92M | -26.7M |
| Net Income | -47.72M | -48.47M | -38.96M | -18.01M | -8.3M | -97.39M | -66.44M | -26.7M |
| Selling & General & Admin | 34.6M | 38.62M | 25.13M | 11.06M | 1.57M | 22.61M | 14.31M | 11.14M |
| Research & Development | 17.5M | 23.46M | 14.55M | 8.93M | 1.32M | 58.02M | 47.02M | 15.66M |
| Other Expenses | 11.39M | -26K | -62K | -74K | n/a | n/a | n/a | n/a |
| Operating Expenses | 63.49M | 62.08M | 39.67M | 19.99M | 2.89M | 80.63M | 61.33M | 26.8M |
| Interest Expense | 3.1M | 1.22M | 1.37M | 690K | 1.49M | n/a | n/a | n/a |
| Selling & Marketing Expenses | 13.51M | 16.49M | 10.9M | 6.93M | 2.25M | n/a | n/a | n/a |
| Cost & Expenses | 74.05M | 73.92M | 46.42M | 22.94M | 11.78M | 80.63M | 61.33M | 26.8M |
| Income Tax | 24K | 24K | 14K | 5K | -486K | -5.57M | -12.48M | 707.18K |
| Shares Outstanding (Basic) | 29.85M | 29.46M | 29.32M | 29.23M | 40.76M | 45M | 29.86M | 29.86M |
| Shares Outstanding (Diluted) | 1.66M | 29.46M | 29.32M | 29.23M | 40.76M | 45M | 29.86M | 29.86M |
| EPS (Basic) | -1.64 | -1.65 | -1.33 | -0.62 | -0.2 | -2.16 | -2.23 | -0.89 |
| EPS (Diluted) | -29.56 | -1.65 | -1.33 | -0.62 | -0.2 | -2.16 | -2.23 | -0.89 |
| EBITDA | -40.49M | -43.62M | -36M | -15.49M | -6.12M | -100.12M | -77.34M | -25.97M |
| Depreciation & Amortization | 4.1M | 2.88M | 1.57M | 1.46M | 857K | 2.84M | 1.58M | 730K |